ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.615,41
-0,38%
S&P 500
5.267,84
0,00%
Dow Jones
39.065,26
0,00%
Euro vs US Dollar
1,08505
0,35%
Bitcoin
67.213,08
-1,05%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. AMEX
  6. Timber Pharmaceuticals Inc (TMBR)

  7. Timber Pharmaceuticals Inc (TMBR) News

TMBR

Timber Pharmaceuticals (TMBR)

Timber Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:TMBR
DatumZeitQuelleÜberschriftSymbolFirma
28/11/202323h21GlobeNewswire Inc.Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE AmericanAMEX:TMBRTimber Pharmaceuticals Inc
18/09/202322h05GlobeNewswire Inc.Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing ComplianceAMEX:TMBRTimber Pharmaceuticals Inc
21/08/202314h00GlobeNewswire Inc.Timber Pharmaceuticals to be Acquired by LEO PharmaAMEX:TMBRTimber Pharmaceuticals Inc
03/07/202322h05GlobeNewswire Inc.Timber Pharmaceuticals Discloses Communication From NYSE AmericanAMEX:TMBRTimber Pharmaceuticals Inc
20/06/202314h00GlobeNewswire Inc.Timber Pharmaceuticals to Present Interim Analyses From Phase 3 ASCEND Study of TMB-001 in Congenital IchthyosisAMEX:TMBRTimber Pharmaceuticals Inc
05/06/202314h00GlobeNewswire Inc.Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001AMEX:TMBRTimber Pharmaceuticals Inc
15/05/202322h15GlobeNewswire Inc.Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial ResultsAMEX:TMBRTimber Pharmaceuticals Inc
31/03/202322h28GlobeNewswire Inc.Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2022 Financial ResultsAMEX:TMBRTimber Pharmaceuticals Inc
20/03/202313h00GlobeNewswire Inc.Timber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental DermatologyAMEX:TMBRTimber Pharmaceuticals Inc
24/02/202314h00GlobeNewswire Inc.Timber Pharmaceuticals Receives European Orphan Drug Designation for TMB-001 in X-Linked Recessive IchthyosisAMEX:TMBRTimber Pharmaceuticals Inc
14/12/202214h30GlobeNewswire Inc.Timber Pharmaceuticals to Host Investor Business Briefing: Milestone Achievements and Forward OutlookAMEX:TMBRTimber Pharmaceuticals Inc
09/12/202222h05GlobeNewswire Inc.Timber Pharmaceuticals Regains Compliance with NYSE American Continued Listing StandardsAMEX:TMBRTimber Pharmaceuticals Inc
14/11/202214h00GlobeNewswire Inc.Timber Pharmaceuticals Provides Business Update and Announces Third Quarter 2022 Financial ResultsAMEX:TMBRTimber Pharmaceuticals Inc
09/11/202214h20Edgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
08/11/202222h38Edgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
08/11/202218h09GlobeNewswire Inc.Timber Pharmaceuticals, Inc. Announces 1-for-50 Reverse Stock SplitAMEX:TMBRTimber Pharmaceuticals Inc
03/11/202213h42Edgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
03/11/202213h22GlobeNewswire Inc.Timber Pharmaceuticals Announces Halt of Common Stock Trading  AMEX:TMBRTimber Pharmaceuticals Inc
26/10/202214h40TipRanksAnalysts Are Bullish on These Healthcare Stocks: Biogen (BIIB), Timber Pharmaceuticals (TMBR)AMEX:TMBRTimber Pharmaceuticals Inc
25/10/202214h31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
25/10/202214h00GlobeNewswire Inc.Timber Pharmaceuticals Receives European Orphan Designation for Autosomal Recessive Congenital Ichthyosis & Positive Comments on Pediatric Investigation Plan for TMB-001 in Autosomal Recessive CI & X-Linked Recessive IchthyosisAMEX:TMBRTimber Pharmaceuticals Inc
03/10/202222h16Edgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
03/10/202216h56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:TMBRTimber Pharmaceuticals Inc
03/10/202215h00GlobeNewswire Inc.Timber Pharmaceuticals Announces $1.3 Million Registered Direct OfferingAMEX:TMBRTimber Pharmaceuticals Inc
14/09/202214h00GlobeNewswire Inc.Timber Pharmaceuticals Receives Positive Opinion on Orphan Designation from European Medicines Agency for TMB-001 for Treatment of Autosomal Recessive Congenital IchthyosisAMEX:TMBRTimber Pharmaceuticals Inc
12/09/202222h43Edgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
02/09/202222h17Edgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
29/08/202222h17Edgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
29/08/202222h05GlobeNewswire Inc.Timber Pharmaceuticals Announces Notification of NYSE American Continued Listing DeficiencyAMEX:TMBRTimber Pharmaceuticals Inc
29/08/202214h00GlobeNewswire Inc.Timber Pharmaceuticals to Highlight Phase 2b CONTROL Study Results in Multiple Presentations at 31st EADV CongressAMEX:TMBRTimber Pharmaceuticals Inc
 Showing the most relevant articles for your search:AMEX:TMBR

Kürzlich von Ihnen besucht

COIN
PRIMUSD
UNSW3
TUSDT
Threshold Network Token
UNSW3
WASETH
Wasder Token
NASDAQ
SMFZX
Amg Systematica Managed ...
KOSPI
550041
NH Investment and Securi...
AQSE
DSG.GB
Dillistone
BITMOT
854551
Gs Fin Corp Mc Dc26 Usd
EU
QQQ3
WisdomTree Multi Asset I...
BIT
P21L30
NLBNPIT21L30 20240918 18...
BIT
P1WXZ4
NLBNPIT1WXZ4 20240920 30
BIT
F18525
Vontobel Financial Produ...
BOV
VALEL325
VALEL325 Ex:32,58
BIT
P21SG8
NLBNPIT21SG8 20240920 170
ASX
MPX
Mustera Property
BIT
P1WTA5
NLBNPIT1WTA5 20251219 29...
BIT
P1UQZ2
NLBNPIT1UQZ2 20240621 9
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten